| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 04/12/2007 | US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases |
| 04/12/2007 | US20070082921 Quinazoline derivatives as antitumor agents |
| 04/12/2007 | US20070082912 Pyrrole compounds for the treatment of prostaglandine mediated diseases |
| 04/12/2007 | US20070082897 Acylated indanyl amines and their use as pharmaceuticals |
| 04/12/2007 | US20070082364 Antibody and use thereof |
| 04/12/2007 | CA2627264A1 Factor h for the treatment of chronic nephropathies and production thereof |
| 04/12/2007 | CA2625340A1 Pharmaceutical composition for treatment or prevention of nephritis and method for producing same |
| 04/12/2007 | CA2624220A1 1- (1h- indol- 1-yl) -3- (methylamino) -1- phenylpropan-2-ol derivatives and related compounds as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (vms) |
| 04/12/2007 | CA2624141A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | CA2624011A1 Normalization or remission of microalbuminuria |
| 04/12/2007 | CA2623657A1 Pde inhibitors and combinations thereof for the treatment of urological disorders |
| 04/11/2007 | EP1772464A2 Methods of identifying indirect agonists of IGF-1 |
| 04/11/2007 | EP1772149A1 Drug for prevention or treatment of diabetes |
| 04/11/2007 | EP1771458A1 N-phenylphosphoric acid triamides, method for the production thereof and their use as agents for regulating or inhibiting enzymatic urea hydrolysis |
| 04/11/2007 | EP1771418A2 Large conductance calcium-activated k channel opener |
| 04/11/2007 | EP1771178A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 04/11/2007 | EP1771166A2 Rxr antagonists in the treatment of inflammatory diseases |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | EP1207868B1 Pharmaceutical tramadol salts |
| 04/11/2007 | EP1015439B1 Prenyl transferase inhibitors |
| 04/11/2007 | EP0988379B1 Ldl-receptor |
| 04/11/2007 | EP0787122B1 Calcium receptor-active compounds |
| 04/11/2007 | CN1944647A Dopamine receptor new sub-type D5B gene and coded protein and use |
| 04/11/2007 | CN1943788A The E type DNA vaccine of Chlamydi trachomatis and its preparation methods and applications |
| 04/11/2007 | CN1943737A A Chinese traditional medicinal composition used for treatment of nephritis and its preparation method |
| 04/11/2007 | CN1943736A A Chinese traditional medicinal composition used for treatment of nephritis and uraemia |
| 04/11/2007 | CN1943701A A kind of medicine for treatment of non-gonococcal urethritis(NGU) and its preparation method |
| 04/11/2007 | CN1943698A A Chinese traditional medicinal composition for treatment of prostatitis and its preparation method |
| 04/11/2007 | CN1943671A The application of the Tibetan picrorhiza rhizome in preparation the medicine for treating kidney disease |
| 04/11/2007 | CN1943669A The Chinese traditional medicinal preparation for treatment of calculus |
| 04/11/2007 | CN1943645A A kind of medicine for treating nephritis |
| 04/11/2007 | CN1943555A Prostatitis plaster |
| 04/11/2007 | CN1943360A Mirobial source herbicide and its preparing method and use |
| 04/11/2007 | CN1309704C Anthranyl amides and their use as medicaments |
| 04/11/2007 | CN1309416C Pharmaceutical composition |
| 04/11/2007 | CN1309380C Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 04/10/2007 | US7202366 Heterocyclic analogs of diphenylethylene compounds |
| 04/10/2007 | US7202344 An antibody or fragment (especially a monoclonal antibody) that binds to specific antigens for use in the diagnosis and treatment of heart, kidney and inflammatory diseases |
| 04/10/2007 | US7202343 Fully human monoclonal antibodies that inhibit neovascularization of solid tumors; assaying for MCP-1; cancer diagnosis; may be conjugated to a chemotherapeutic agent such as taxol, doxorubicin, cis-platinum, and 5-fluorouracil. |
| 04/10/2007 | US7202278 Combined with a statin, ACE-inhibitor, PDE V-inhibitor, Ca-antagonist, beta-blocker, arginine, or tetrahydrobiopterin; for treatment of conditions including cardiovascular disorders, erectile dysfunction, therapy and prophylaxis of diabetes including its complicatons, and respiratory diseases |
| 04/10/2007 | US7202276 Use of 13-HODE as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 04/10/2007 | US7202273 Prevention of menopausal syndrome |
| 04/10/2007 | US7202267 Acyloxypyrrolidine derivatives, preparation thereof and application thereof in therapeutic |
| 04/10/2007 | US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure |
| 04/10/2007 | US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2007 | US7202242 Substituted 1 and 2-naphthol Mannich bases |
| 04/10/2007 | US7202238 Diazabicyclo alkane derivatives with NK1 antagonistic activity |
| 04/10/2007 | US7202208 Erythropoietin composition |
| 04/10/2007 | US7202057 DNAs encoding rat histamine receptors of the H4 subtype |
| 04/10/2007 | US7201895 High-affinity antagonists of ELR-CXC chemokines |
| 04/05/2007 | WO2007037554A1 Adsorbent for advanced glycation endproducts |
| 04/05/2007 | WO2007037513A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 04/05/2007 | WO2007036543A1 Beta-3-agonist use for treating kidney and bladder troubles of a patient with spinal cord damages |
| 04/05/2007 | WO2007010504A3 Acid addition salts of isoindoles acting as adrenergic receptor antagonists |
| 04/05/2007 | WO2006099468A3 Process for the purification of duloxetine hydrochloride |
| 04/05/2007 | US20070078091 Pharmaceutical combinations for compensating for a testosterone deficiency in men while simultaneously protecting the prostate |
| 04/05/2007 | US20070077597 Method for identifying modulators of G protein coupled receptor signaling |
| 04/05/2007 | US20070077232 Conditioned cell culture medium compositions and methods of use |
| 04/05/2007 | DE102004015752B4 Verwendung von Gabapentin-Laktam zur Behandlung renaler Erkrankungen Use of gabapentin-lactam for treatment of renal diseases |
| 04/05/2007 | CA2624162A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 04/05/2007 | CA2623652A1 Antibody-drug conjugates and methods of use |
| 04/04/2007 | EP1770161A2 BMP-11 compositions |
| 04/04/2007 | EP1769800A2 Estrogen replacement therapy |
| 04/04/2007 | EP1769792A1 Use of a beta-3 adrenoceptor agonist for the treatment of renal and bladder problems |
| 04/04/2007 | EP1768948A1 Substituted amino compounds as 5-ht/na uptake inhibitors |
| 04/04/2007 | EP1536797B1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough |
| 04/04/2007 | CN1942200A Use of low-dose erythropoietin for stimulating endothelial precursor cells, regenerating organs, and slowing down progression of end organ damages |
| 04/04/2007 | CN1942196A Adsorbent for oral administration and therapeutic agent or prophylactic agent for kidney disease and therapeutic agent or prophylactic agent for liver disease |
| 04/04/2007 | CN1942181A Tablet containing branched chain amino acid and process for producing the same |
| 04/04/2007 | CN1940068A Novel receptor nucleic acids and polypeptides |
| 04/04/2007 | CN1939541A Immunostimulatory nucleic acids |
| 04/04/2007 | CN1939531A Use of botulinum toxin for the treatment of unstable bladder |
| 04/04/2007 | CN1939503A Specific toxin-removing and kidney-tonifying prescription |
| 04/04/2007 | CN1939495A Ointment preparation for treating urinaemia |
| 04/04/2007 | CN1939460A Chinese-medicinal preparation with kidney-yang tonifying function and its making method |
| 04/04/2007 | CN1939453A Gambir plant extract and its use in preparation of target organ protective medicine |
| 04/04/2007 | CN1939437A Medicine for treating nephrolithiasis |
| 04/04/2007 | CN1939431A Medicine for treating prostatic accrementition |
| 04/04/2007 | CN1939332A Medical usage of S-adenyhomotype cysteine |
| 04/04/2007 | CN1939330A Medical usage of milkvetch-root methcoside |
| 04/04/2007 | CN1308329C Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 04/04/2007 | CN1308324C Quinazoline derivatives as alpha-1 adrenergic antagonists |
| 04/04/2007 | CN1308320C Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 04/04/2007 | CN1308313C Fused azepine drivatives and their use as antidiuretic agents |
| 04/04/2007 | CN1307993C Macrolides-containing pharmaceutical compositions |
| 04/04/2007 | CN1307988C Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 04/04/2007 | CN1307987C Novel usage of alkannin |
| 04/03/2007 | US7199229 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |
| 04/03/2007 | US7199150 Amino alcohol compounds |
| 04/03/2007 | US7199147 Rho kinase inhibitors |
| 04/03/2007 | US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments |
| 04/03/2007 | US7199142 1-((5-aryl-1,2,4-oxadiazol-3-yl) benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl) pyrrolidine-3-carboxylates as edg receptor agonists |
| 04/03/2007 | US7199130 Substituted 5,6,6a, 11b-tetrahydro-7-oxa-5-aza-benzo[c]fluorene-6-carboxylic acid compounds as NMDA-antagonists |
| 04/03/2007 | US7199124 Antiinflammatory agents; antiarthritic agents; immunomoderators |
| 04/03/2007 | US7198913 Nucleotide sequences coding polypeptide for use in the treatment of apoptosis, inflammatory and autoimmune disorders |
| 04/03/2007 | CA2289570C 9-azabicyclo(3.3.1)non-2-ene and nonane derivatives as cholinergic ligands at nicotinic ach receptors |
| 04/03/2007 | CA2236269C Selective .beta.3 adrenergic agonists |
| 03/29/2007 | WO2007035911A1 System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid compositions |